[1] Awasthi, R., Manchanda, S., Das, P., & Velu, V. et. al (2018). Poly(vinylpyrrolidone). En A. Parambath, Engineering of Biomaterials for Drug Delivery Systems: Beyond Polyethylene Glycol. Vancouver, Canada: Woodhead Publishing.

[2] M. Guillon, C. Maissa, P. Pouliquen y L. Delval, «Effect of Povidone 2% Preservative-free Eyedrops on Contact Lens Wearers with Computer Visual Syndrome,» Eye & Contact Lens, vol. 30, nº 1, pp. 34 – 39, 2004.

[3] PubChem, «Boric acid,» U.S. National Library of Medicine, [En línea]. Available: https://pubchem.ncbi.nlm.nih.gov/compound/boric_acid#section=Pharmacology-and-Biochemistry. [Último acceso: 10 Noviembre 2021].

[4] J. Aronson, Meyler’s Side Effect of Drugs The International Encyclopedia of adverse Drug Reactions and Interactions, Oxford, UK: Elsevier, 2016.

[5] H. Pult, P. Murphy y C. Purslow, «A Novel Method to Predict the Dry Eye Symptoms in New Contact Lens Wearers,» OPTOMETRY AND VISION SCIENCE, vol. 86, nº 9, p. E1042–E1050, 2009.

[6] J. Nichols y L. Sinnott, «Tear Film, Contact Lens, and Patient-Related Factors Associated with Contact Lens–Related Dry Eye,» Clinical and Epidemiologic Research, vol. 47, nº 4, pp. 1319-1328, 2006.

[7] Bausch & Lomb. ReNu MultiPlus® Lubricating & Rewetting Drops. Rochester, NY: Bausch & Lomb. [En línea] [19 de enero del 2017] Pp. http://www.bausch.com/Portals/107/-/m/BL/United%20States/USFiles/Package%20Inserts/Vision%20Care/renumultiplusrewettingdropspackageinsert.pdf

[8] A. Wright, M. Mowrey-McKee, «Comparative cytotoxicity potential of soft contact lens care products », Cutaneous and Ocular Toxicology, Vol. 24, nº 1, pp. 53-64, 2015.

[9] EMA/CHMP/495737/2013. Committee for Human Medicinal Products (CHMP). Questions and answers on benzalkonium chloride used as an excipient in medicinal products for human use. 2017